Related references
Note: Only part of the references are listed.Molecular mechanisms underlying chemopreventive potential of butein: Current trends and future perspectives
Hardeep Singh Tuli et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2021)
Licochalcone A inhibits EGFR signalling and translationally suppresses survivin expression in human cancer cells
Feng Gao et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
BIRC3 and BIRC5: multi-faceted inhibitors in cancer
Raffaele Frazzi
CELL AND BIOSCIENCE (2021)
A survivin-driven, tumor-activatable minicircle system for prostate cancer theranostics
TianDuo Wang et al.
MOLECULAR THERAPY-ONCOLYTICS (2021)
Probiotic Saccharomyces cerevisiae var. boulardii supernatant inhibits survivin gene expression and induces apoptosis in human gastric cancer cells
Babak Pakbin et al.
FOOD SCIENCE & NUTRITION (2021)
The diagnostic value of EBV-DNA and EBV-related antibodies detection for nasopharyngeal carcinoma: a meta-analysis
Weixing Liu et al.
CANCER CELL INTERNATIONAL (2021)
Targeting Aurora B kinase with Tanshinone IIA suppresses tumor growth and overcomes radioresistance
Ming Li et al.
CELL DEATH & DISEASE (2021)
The Current Role of Adjuvant Chemotherapy in Locally Advanced Nasopharyngeal Carcinoma
Lin Su et al.
FRONTIERS IN ONCOLOGY (2021)
The prognostic significance of survivin expression in patients with HNSCC: a systematic review and meta-analysis
Liu-qing Zhou et al.
BMC CANCER (2021)
The Evolving Epidemiology of Nasopharyngeal Carcinoma
Ellen T. Chang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2021)
Mutant p53 regulates Survivin to foster lung metastasis
Qiaosi Tang et al.
GENES & DEVELOPMENT (2021)
Roles of Inflammasomes in Epstein-Barr Virus-Associated Nasopharyngeal Cancer
Chin King Looi et al.
CANCERS (2021)
Prognostic Significance of BIRC5/Survivin in Breast Cancer: Results from Three Independent Cohorts
Nina Oparina et al.
CANCERS (2021)
Targeted RNAi of BIRC5/Survivin Using Antibody-Conjugated Poly(Propylene Imine)-Based Polyplexes Inhibits Growth of PSCA-Positive Tumors
Willi Jugel et al.
PHARMACEUTICS (2021)
Current approach and novel perspectives in nasopharyngeal carcinoma: the role of targeting proteasome dysregulation as a molecular landmark in nasopharyngeal cancer
Ramon Yarza et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
miR-34a-Mediated Survivin Inhibition Improves the Antitumor Activity of Selinexor in Triple-Negative Breast Cancer
Silvia Martini et al.
PHARMACEUTICALS (2021)
Prognostic Value of Survivin in Nasopharyngeal Carcinoma: A Systematic Review and Meta-analysis
Wenji Xie et al.
JOURNAL OF CANCER (2021)
The survivin molecule as a double-edged sword in cellular physiologic and pathologic conditions and its role as a potential biomarker and therapeutic target in cancer
Atieh Rafatmanesh et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Functional Compartmentalization of HSP60-Survivin Interaction between Mitochondria and Cytosol in Cancer Cells
Ya-Hui Huang et al.
CELLS (2020)
Promotion of ubiquitination-dependent survivin destruction contributes to xanthohumol-mediated tumor suppression and overcomes radioresistance in human oral squamous cell carcinoma
Ming Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Chemotherapy and chemo-resistance in nasopharyngeal carcinoma
Shuzhen Guan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Emerging Importance of Survivin in Stem Cells and Cancer: the Development of New Cancer Therapeutics
Neerada Meenakshi Warrier et al.
STEM CELL REVIEWS AND REPORTS (2020)
Roles of β-catenin, TCF-4, and survivin in nasopharyngeal carcinoma: correlation with clinicopathological features and prognostic significance
Pei-Ying Jin et al.
CANCER CELL INTERNATIONAL (2019)
Brexpiprazole, a Serotonin-Dopamine Activity Modulator, Can Sensitize Glioma Stem Cells to Osimertinib, a Third-Generation EGFR-TKI, via Survivin Reduction
Shuhei Suzuki et al.
CANCERS (2019)
Ovarian Primary and Metastatic Tumors Suppressed by Survivin Knockout or a Novel Survivin Inhibitor
Guannan Zhao et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Skp2-mediated ubiquitination and mitochondrial localization of Akt drive tumor growth and chemoresistance to cisplatin
Xinfang Yu et al.
ONCOGENE (2019)
Survivin in Insulin-Like Growth Factor-Induced Resistance to Lapatinib in Head and Neck Squamous Carcinoma Cells
Christine E. Lehman et al.
FRONTIERS IN ONCOLOGY (2019)
CSN5/Jab1 facilitates non-small cell lung cancer cell growth through stabilizing survivin
Jie Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
YM155 sensitizes non-small cell lung cancer cells to EGFR-tyrosine kinase inhibitors through the mechanism of autophagy induction
Chun-Hua Dai et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
Ubiquitin-like protein FAT10 promotes bladder cancer progression by stabilizing survivin
Dingxiang Dong et al.
ONCOTARGET (2016)
The Proapoptotic F-box Protein Fbxl7 Regulates Mitochondrial Function by Mediating the Ubiquitylation and Proteasomal Degradation of Survivin
Yuan Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Survivin: A new target for anti-cancer therapy
Brid M. Ryan et al.
CANCER TREATMENT REVIEWS (2009)
Phase I and Pharmacokinetic Study of YM155, a Small-Molecule Inhibitor of Survivin
Anthony W. Tolcher et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Opinion - Survivin, cancer networks and pathway-directed drug discovery
Dario C. Altieri
NATURE REVIEWS CANCER (2008)
Degradation of survivin by the x-linked inhibitor of apoptosis (XIAP)-XAF1 complex
Vinay Arora et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin
DS O'Connor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)